简体中文 | 繁體中文 | English

Products & Services News

2022-02-23 19:05 Integromat Evolves to Make, Expanding Its Vision to Empower Creators to Innovate Without Limits
2022-02-23 16:52 IMS Group Continues Its Rapid Expansion by Opening a New Office in London
2022-02-23 16:49 Andersen Global Enters Collaboration Agreement with Bahrain-Based Law Firm
2022-02-23 16:40 DEWA’s Nanosatellite DEWA-SAT1 is Stable in its Low Earth Orbit
2022-02-23 15:02 Radisys Launches 5G IoT Software Suite
2022-02-22 19:01 Kaneka Eurogentec Announces the Successful Production of 25g of mRNA in One Batch
2022-02-22 18:59 Lenovo Selected as a Constituent Stock of the Hang Seng Index
2022-02-22 16:58 Hytera Communication Solution Assists FIFA Arab Cup 2021
2022-02-22 13:35 CORRECTING and REPLACING 62% of Financial Services Leaders Expect Their Cloud Investments to Increase Revenue Over Next Two Years
2022-02-22 13:30 Servify Acquires 247around, an At-Home Service Platform Specialising in Connecting Consumers with OEMs’ Service Network
2022-02-22 10:51 Saudi Fund for Development Inaugurated New Infrastructure Projects in Djibouti Worth US$ 137 Million
2022-02-22 10:00 ABLIC Launches the S-19255 Series, the Industry’s Smallest (*1) High PSRR Automotive LDO Linear Regulators
2022-02-22 09:42 FINEOS Announces Strong Adoption in 2021 of Updated Purpose-Built FINEOS Platform Among Tier-1&2 Employee Benefits Insurance Carrier Clients
2022-02-22 09:25 NICE Alliance Provides Total Solutions to Accelerate Expansion of Ecosystem With Launch of Platform as a Service (PaaS) Powered by Microsoft Azure
2022-02-21 20:16 Thales Expands Relationship with Google Cloud to Increase Customer Trust in the Cloud
2022-02-21 20:15 Tetrate Delivers Industry-First Application Connectivity Platform That Combines API Gateway, WAF and Service Mesh Capabilities, With API Governance Out-of-the-Box
2022-02-21 20:11 Karen L. Ling joins Galderma’s Advisory Committee
2022-02-21 15:37 Prestige BioPharma’s Herceptin Biosimilar, Tuznue®, Receives EU-GMP Certification
2022-02-21 14:16 Regencell Bioscience’s Investigational Liquid-Formula RGC-COV19TM Shows Effectiveness Through Its Enrolled Patients in Eliminating Mild to Moderate COVID-19 Symptoms within the 6-day Treatment Period in its EARTH Efficacy Trial
2022-02-21 11:46 Bluehole Publishes an Industry Comment on BAT 2021 Preliminary Results

Business Wire Weibo

Press Releases

Latest Releases